ストックスクリーナーアプリを入手
3.07
5.25%
-0.17
アフターアワーズ：
3.07
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
Risks Report: Is Cumberland Pharmaceuticals Inc stock a top performer YTD2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
CPIX Technical Analysis & Stock Price Forecast - intellectia.ai
Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - Barchart.com
Asthma Market: High-Growth Opportunities for Investors to 2034 - openpr.com
Aug Catalysts: Why is Cumberland Pharmaceuticals Inc stock going up2026 Opening Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
EV Market: Is Cumberland Pharmaceuticals Inc backed by strong institutional buyingMarket Growth Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Cumberland Pharmaceuticals (CPIX) receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director granted 1,800 shares in Form 4 filing - Stock Titan
[Form 4] CUMBERLAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Cumberland (CPIX) director Caroline Young receives 1,800-share stock grant - Stock Titan
Cumberland (CPIX) VP awarded 3,000 stock options at $2.80 strike - Stock Titan
Cumberland (CPIX) VP awarded options to buy 3,000 shares at $2.80 - Stock Titan
Cumberland Pharmaceuticals (CPIX) CFO granted 3,000 stock options - Stock Titan
Cumberland Pharmaceuticals (CPIX) CEO granted 100,000 stock options - Stock Titan
Retail Trends: What makes Cumberland Pharmaceuticals Inc stock attractive todayIndex Update & Precise Swing Trade Alerts - baoquankhu1.vn
Cumberland (NASDAQ: CPIX) CEO A.J. Kazimi reports routine tax-withholding share disposition - Stock Titan
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion - MSN
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting - PR Newswire
New site spotlights chemo nausea patch that helps for five days - Stock Titan
Cumberland Pharmaceuticals Stock Rating Upgraded - National Today
Aug Macro: What is the dividend yield of Cumberland Pharmaceuticals Inc2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
[ARS] CUMBERLAND PHARMACEUTICALS INC SEC Filing - Stock Titan
Trend Report: Can Cumberland Pharmaceuticals Inc beat the S P 500Trade Exit Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart.com
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ: CPIX) details 2026 director, pay and auditor votes - Stock Titan
Cumberland Pharmaceuticals Inc. Business Overview, Product Portfolio, Growth Strategy, and International Partnerships 2025 - Minichart
Cumberland Pharmaceuticals 2025 10-K — Revenue $44.5M, Net loss $2.9M - TradingView
Swing Trade: What is the dividend yield of Cumberland Pharmaceuticals IncPortfolio Risk Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
How resilient is Cumberland Pharmaceuticals Inc. stock in market downturns2026 Rallies & Low Volatility Stock Recommendations - Naître et grandir
Risk Recap: Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Aug Highlights: Can Cumberland Pharmaceuticals Inc reach all time highs this year - baoquankhu1.vn
Momentum Shift: Is Cumberland Pharmaceuticals Inc in a bullish channelTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - AOL.com
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - AOL.com
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
147M H. pylori patients set stage for new stomach infection drugs - Stock Titan
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland Pharmaceuticals Reports 31% Q4 2025 Revenue Growth, Expands Internationally, and Achieves Key Clinical and Financial Milestones - Minichart
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland: Q4 Earnings Snapshot - GreenevilleSun.com
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Joint U.S. Commercialization of RedHill's Talicia® Commences - marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
H. pylori drug Talicia rolls out in U.S. as infection hits 35% of adults - Stock Titan
Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan
Volume Report: Why is Cumberland Pharmaceuticals Inc stock going upWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Merger Talk: Can Cumberland Pharmaceuticals Inc reach all time highs this yearPrice Action & Weekly Top Performers Watchlists - baoquankhu1.vn
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - AOL.com
2.11%
1.06%
大文字化:
|
ボリューム (24 時間):